Close Menu
Indian Markets
Block Deals
Commodities
Earnings Reports
Global Insights
Bonds
Market Analysis
Recent Posts
NSE Index Closes Slightly Lower, Reflecting Minor Market Adjustments
GIFT NIFTY Starts the Day with a Positive Uptick
FII Sells Net Rupees 4,486.41 Crore of India Shares; DII Buys Net Rupees 4,001.
NSE Index Opens Slightly Higher in Pre-Open Trade
GIFT Nifty Futures Open Higher, Signaling Positive Market Sentiment
Search for:
English
हिन्दी
Archives
February 2025
January 2025
December 2024
November 2024
October 2024
July 2024
WhatsApp
WhatsApp
English
हिन्दी
Indian Markets
Block Deals
Commodities
Earnings Reports
Global Insights
Bonds
Market Analysis
English
हिन्दी
Indian Markets
Block Deals
Commodities
Earnings Reports
Global Insights
Bonds
Market Analysis
Home
»
Biocon
Browsing:
Biocon
2 weeks ago
2 weeks ago
Biocon Expects Strong Growth in Q4FY25 and Beyond
2 weeks ago
Biocon to Issue ₹570 Crore in Commercial Papers
3 weeks ago
3 weeks ago
Biocon to Explore Fundraising Options on January 27th
1 month ago
1 month ago
Biocon Biologics’ Malaysian Facility Receives VAI Classification from US FDA
1 month ago
Biocon Biologics Receives Approval for Ustekinumab Biosimilar in Japan
2 months ago
2 months ago
Biocon Receives USFDA EIR with Voluntary Action Indicated Status for Bengaluru Facility
2 months ago
Biocon Wins FDA Approval for Generic Versions of Victoza and Saxenda
2 months ago
Biocon Sells Syngene International Shares in Block Deal
2 months ago
Biocon to Divest Up to 2% Stake in Syngene International via Block Deal
4 months ago
4 months ago
Amgen Beats Biocon to Market with Eylea Biosimilar, Impacting Biocon’s Outlook
Load More
Submit
Type above and press
Enter
to search. Press
Esc
to cancel.
Enable Notifications
OK
No thanks